Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

ReGen Biologics raises funds for Menaflex launch: U.S. launch of collagen knee cartilage repair implant in February will be supported in part by proceeds from a $10 million private placement of common stock, announced Jan. 21. The Hackensack, N.J., firm completed the first $7 million in funding on Jan. 16 and will raise $3 million more in a planned second stage, ReGen explains. The financing round was led by Sanderling Venture Partners. Menaflex gained 510(k) clearance in December (1"The Gray Sheet" Jan. 5, 2009, p. 24)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT027032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel